Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00416312 · COMPLETED
Trial details
- NCT number
- NCT00416312
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-10-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.